StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Jiangsu Hengrui Medicine Co., Ltd.
Shanghai Stock Exchange:600276.SS
Sector
Location
Market Cap
USD 51.03 B
Share Price
USD 7.44
Avg Daily Volume
45,260,884
Change (1 day)
1.44%
Change (1 year)
37.99%
Change (YTD)
18.38%
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin for the year ending December 31, 2024: 86.25%
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin is 86.25% for the year ending December 31, 2024, a 2.01% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin for the year ending December 31, 2023 was 84.55%, a 1.12% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 83.61%, a -2.27% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 85.56%, a -2.70% change year over year.
-
Jiangsu Hengrui Medicine Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 87.93%, a 0.50% change year over year.
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%
Key Data
| Date | Gross Profit Margin | EBIT Margin | EBITDA Margin | Net Income Margin |
|---|
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Novartis AG
USD 122.54
NOVN.SW
+0.43
0.36%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%